In-depth mapping of the mouse brain N-glycoproteome reveals widespread N-glycosylation of diverse brain proteins

Oncotarget

Volumn 7, Issue 25, 2016, Pages 38796-38809

  Fang, Pan ^a   Wang, Xin Jian ^a   Xue, Yu ^a   Liu, Ming Qi ^a   Zeng, Wen Feng ^b   Zhang, Yang ^a   Zhang, Lei ^a   Gao, Xing ^a   Yan, Guo Quan ^a   Yao, Jun ^a   Shen, Hua Li ^a   Yang, Peng Yuan ^a  

^a FUDAN UNIVERSITY   (China)

^b INSTITUTE OF COMPUTING TECHNOLOGY   (China)

Author keywords

Brain physiological activities; Disease biomarker; Mass spectrometry; Mouse brain; N glycoproteomics

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; GLUTAMATE RECEPTOR; GLYCOPEPTIDE; PROTEOME; BIOLOGICAL MARKER; GLYCOPROTEIN;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYDROPHILIC INTERACTION CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; MORPHOGENESIS; MOUSE; NONHUMAN; POSTSYNAPTIC MEMBRANE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; REVERSED PHASE LIQUID CHROMATOGRAPHY; SIALYLATION; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; UBIQUITINATION; ANIMAL; BIOLOGY; BRAIN; C57BL MOUSE; GLYCOSYLATION; METABOLISM; PH; PROTEOMICS; TANDEM MASS SPECTROMETRY;

ANIMALS; BIOMARKERS; BRAIN; COMPUTATIONAL BIOLOGY; GLYCOPROTEINS; GLYCOSYLATION; HYDROGEN-ION CONCENTRATION; MALE; MICE; MICE, INBRED C57BL; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84978066674     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9737     Document Type: Article

References (41)

1. Zaia J. Mass spectrometry and the emerging field of glycomics. Chem Biol. 2008; 15:881-892.
2. Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006; 126: 855-867.
3. Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev. 2010; 29:79-125.
4. Schedin-Weiss S, Winblad B, Tjernberg LO. The role of protein glycosylation in Alzheimer disease. FEBS J. 2014; 281:46-62.
5. Liao J, Zhang R, Qian H, Cao L, Zhang Y, Xu W, Li J, Wu M, Yin Z. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma. Biochem Biophys Res Commun. 2012; 420:308-314.
6. Hudak JE, Bertozzi CR. Glycotherapy: new advances inspire a reemergence of glycans in medicine. Chem Biol. 2014; 21:16-37.
7. Zielinska DF, Gnad F, Wisniewski JR, Mann M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell. 2010; 141: 897-907.
8. Zielinska DF, Gnad F, Schropp K, Wisniewski JR, Mann M. Mapping N-glycosylation sites across seven evolutionarily distant species reveals a divergent substrate proteome despite a common core machinery. Mol Cell. 2012; 46:542-548.
9. Parker BL, Palmisano G, Edwards AV, White MY, Engholm-Keller K, Lee A, Scott NE, Kolarich D, Hambly BD, Packer NH, Larsen MR, Cordwell SJ. Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment. Mol Cell Proteomics. 2011; 10:M110.006833. doi: 006810.001074/mcp.M006110.006833.
10. Kaji H, Shikanai T, Sasaki-Sawa A, Wen H, Fujita M, Suzuki Y, Sugahara D, Sawaki H, Yamauchi Y, Shinkawa T, Taoka M, Takahashi N, Isobe T, et al. Large-scale identification of N-glycosylated proteins of mouse tissues and construction of a glycoprotein database, GlycoProtDB. J Proteome Res. 2012; 11:4553-4566.
11. Chen W, Smeekens JM, Wu R. A Universal Chemical Enrichment Method for Mapping the Yeast N-glycoproteome by MS. Mol Cell Proteomics. 2014; 13:1563-1572.
12. Zhu J, Sun Z, Cheng K, Chen R, Ye M, Xu B, Sun D, Wang L, Liu J, Wang F, Zou H. Comprehensive mapping of protein N-glycosylation in human liver by combining hydrophilic interaction chromatography and hydrazide chemistry. J Proteome Res. 2014; 13:1713-1721.
13. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta. 1999; 1473:4-8.
14. Zhang Y, Zhang C, Jiang H, Yang P, Lu H. Fishing the PTM proteome with chemical approaches using functional solid phases. Chem Soc Rev. 2015; 44:8260-8287.
15. Alley WR Jr, Mann BF, Novotny MV. High-sensitivity analytical approaches for the structural characterization of glycoproteins. Chem Rev. 2013; 113:2668-2732.
16. Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009; 8:651-661.
17. Zhao X, Ma C, Han H, Jiang J, Tian F, Wang J, Ying W, Qian X. Comparison and optimization of strategies for a more profound profiling of the sialylated N-glycoproteomics in human plasma using metal oxide enrichment. Anal Bioanal Chem. 2013; 405:5519-5529.
18. Ma C, Zhao X, Han H, Tong W, Zhang Q, Qin P, Chang C, Peng B, Ying W, Qian X. N-linked glycoproteome profiling of human serum using tandem enrichment and multiple fraction concatenation. Electrophoresis. 2013; 34:2440-2450.
19. Lewandrowski U, Zahedi RP, Moebius J, Walter U, Sickmann A. Enhanced N-glycosylation site analysis of sialoglycopeptides by strong cation exchange prefractionation applied to platelet plasma membranes. Mol Cell Proteomics. 2007; 6:1933-1941.
20. 2 chromatography. Glycoconj J. 2012; 29:433-443.
21. Palmisano G, Melo-Braga MN, Engholm-Keller K, Parker BL, Larsen MR. Chemical deamidation: a common pitfall in large-scale N-linked glycoproteomic mass spectrometry-based analyses. J Proteome Res. 2012; 11:1949-1957.
22. O'Shea JP, Chou MF, Quader SA, Ryan JK, Church GM, Schwartz D. pLogo: a probabilistic approach to visualizing sequence motifs. Nat Methods. 2013; 10:1211-1212.
23. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4:44-57.
24. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004; 44:5-21.
25. Sweatt JD. Toward a molecular explanation for long-term potentiation. Learn Mem. 1999; 6:399-416.
26. Jiang J, Suppiramaniam V, Wooten MW. Posttranslational modifications and receptor-associated proteins in AMPA receptor trafficking and synaptic plasticity. Neurosignals. 2006; 15:266-282.
27. Gu W, Fukuda T, Isaji T, Hang Q, Lee HH, Sakai S, Morise J, Mitoma J, Higashi H, Taniguchi N, Yawo H, Oka S, Gu J. Loss of alpha1, 6-fucosyltransferase decreases hippocampal long term potentiation: implictions for core fucosylation in the regulation of AMPA receptor heteromerization and cellular signaling. J Biol Chem. 2015; 290:17566-17575.
28. Matthies HJ, Kretlow J, Matthies H, Smalla KH, Staak S, Krug M. Glycosylation of proteins during a critical time window is necessary for the maintenance of long-term potentiation in the hippocampal CA1 region. Neuroscience. 1999; 91:175-183.
29. Nabavi S, Fox R, Proulx CD, Lin JY, Tsien RY, Malinow R. Engineering a memory with LTD and LTP. Nature. 2014; 511:348-352.
30. Goedert M, Spillantini MG. A century of Alzheimer's Disease. Science. 2006; 314:777-781.
31. Querfurth HW, LaFerla FM. Mechanisms Of Disease Alzheimer's Disease. New Engl J Med. 2010; 362:329-344.
32. Butterfield DA, Owen JB. Lectin-affinity chromatography brain glycoproteomics and Alzheimer disease: insights into protein alterations consistent with the pathology and progression of this dementing disorder. Proteomics Clin Appl. 2011; 5:50-56.
33. Botella-Lopez A, Burgaya F, Gavin R, Garcia-Ayllon MS, Gomez-Tortosa E, Pena-Casanova J, Urena JM, Del Rio JA, Blesa R, Soriano E, Saez-Valero J. Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc Natl Acad Sci. 2006; 103:5573-5578.
34. Sáez-Valero J, Sberna G, McLean CA, Small DH. Molecular Isoform Distribution and Glycosylation of Acetylcholinesterase Are Altered in Brain and Cerebrospinal Fluid of Patients with Alzheimer's Disease. J Neurochem. 1999; 72:1600-1608.
35. Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D. CSF N-glycoproteomics for early diagnosis in Alzheimer's disease. J Proteomics. 2016; 131:29-37.
36. Kizuka Y, Kitazume S, Fujinawa R, Saito T, Iwata N, Saido TC, Nakano M, Yamaguchi Y, Hashimoto Y, Staufenbiel M, Hatsuta H, Murayama S, Manya H, et al. An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease. EMBO Mol Med. 2015; 7:175-189.
37. Liu Y, Qing H, Deng Y. Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics. Int J Mol Sci. 2014; 15:7865-7882.
38. Mueller TM, Haroutunian V, Meador-Woodruff JH. N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia. Neuropsychopharmacol. 2014; 39: 528-537.
39. Freeze HH, Eklund EA, Ng BG, Patterson MC. Neurological aspects of human glycosylation disorders. Annu Rev Neurosci. 2015; 38:105-125.
40. Weng Y, Sui Z, Jiang H, Shan Y, Chen L, Zhang S, Zhang L, Zhang Y. Releasing N-glycan from peptide N-terminus by N-terminal succinylation assisted enzymatic deglycosylation. Sci Rep. 2015; 5:9770.
41. Atwood JA, 3rd, Sahoo SS, Alvarez-Manilla G, Weatherly DB, Kolli K, Orlando R, York WS. Simple modification of a protein database for mass spectral identification of N-linked glycopeptides. Rapid Commun Mass Spectrom. 2005; 19:3002-3006.